Gilead Sciences, Inc. (GILD)
159.08
+0.39
(+0.25%)
USD |
NASDAQ |
Oct 27, 16:00
159.37
+0.29
(+0.18%)
After-Hours: 17:38
Gilead Sciences Total Return Level : 232.58 for Oct. 26, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 26, 2026 | 232.58 |
| October 23, 2026 | 228.69 |
| October 22, 2026 | 230.38 |
| October 21, 2026 | 225.07 |
| October 20, 2026 | 229.38 |
| October 19, 2026 | 224.34 |
| October 16, 2026 | 228.91 |
| October 15, 2026 | 230.64 |
| October 14, 2026 | 225.03 |
| October 13, 2026 | 216.79 |
| October 12, 2026 | 220.47 |
| October 09, 2026 | 221.55 |
| October 08, 2026 | 215.59 |
| October 07, 2026 | 215.22 |
| October 06, 2026 | 211.38 |
| October 05, 2026 | 211.97 |
| October 02, 2026 | 212.13 |
| October 01, 2026 | 216.18 |
| September 30, 2026 | 218.45 |
| September 29, 2026 | 221.72 |
| September 28, 2026 | 223.08 |
| September 25, 2026 | 221.20 |
| September 24, 2026 | 219.39 |
| September 23, 2026 | 221.85 |
| September 22, 2026 | 223.75 |
| Date | Value |
|---|---|
| September 21, 2026 | 220.66 |
| September 18, 2026 | 220.00 |
| September 17, 2026 | 221.14 |
| September 16, 2026 | 216.44 |
| September 15, 2026 | 214.42 |
| September 14, 2026 | 213.38 |
| September 11, 2026 | 209.46 |
| September 10, 2026 | 211.05 |
| September 09, 2026 | 212.27 |
| September 08, 2026 | 213.72 |
| September 04, 2026 | 220.06 |
| September 03, 2026 | 220.39 |
| September 02, 2026 | 218.05 |
| September 01, 2026 | 218.50 |
| August 31, 2026 | 213.28 |
| August 28, 2026 | 212.32 |
| August 27, 2026 | 216.95 |
| August 26, 2026 | 215.83 |
| August 25, 2026 | 216.82 |
| August 24, 2026 | 213.86 |
| August 21, 2026 | 212.96 |
| August 20, 2026 | 209.05 |
| August 19, 2026 | 215.12 |
| August 18, 2026 | 209.05 |
| August 17, 2026 | 202.47 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 496.93 |
| Vertex Pharmaceuticals, Inc. | 517.49 |
| Amgen, Inc. | 665.80 |
| Biogen, Inc. | 252.26 |
| Johnson & Johnson | 635.45 |